Cite

HARVARD Citation

    Guo, X. et al. (2016). PAC1R agonist maxadilan enhances hADSC viability and neural differentiation potential. Journal of cellular and molecular medicine. 20 (5), pp. 874-890. [Online]. 
  
Back to record